Zobrazeno 1 - 10
of 25
pro vyhledávání: '"J J Willey"'
Publikováno v:
Clinical Chemistry. 38:873-879
We describe the characterization and utility of a new electrochemiluminescent (ECL) label for oligonucleotides, utilizing phosphoramidite chemistry. This phosphoramidite of the tris(2,2-bipyridine)ruthenium(II) complex, bis(2,2-bipyridine)(4-[4-(2-cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f91a040c71c78e5d192af352f6779a0
https://doi.org/10.1093/clinchem/38.6.873
https://doi.org/10.1093/clinchem/38.6.873
Publikováno v:
Clinical Chemistry. 37:1626-1632
We demonstrate the first use of an electrochemiluminescent (ECL) label, [4-(N-succimidyloxycarbonylpropyl)-4'-methyl-2,2'- bipyridine]ruthenium(II) dihexafluorophosphate (Origen label; IGEN Inc.), in DNA probe assays. This label allows rapid (less th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7414084bc4c5779870a26f654b55abe5
https://doi.org/10.1093/clinchem/37.9.1626
https://doi.org/10.1093/clinchem/37.9.1626
Autor:
E C, Henry, A S, Kende, G, Rucci, M J, Totleben, J J, Willey, S D, Dertinger, R S, Pollenz, J P, Jones, T A, Gasiewicz
Publikováno v:
Molecular pharmacology. 55(4)
Previous analyses suggested that potent aryl hydrocarbon receptor (AhR) antagonists were planar, with a lateral electron-rich center. To further define structural requirements and mechanism for antagonism, ten additional flavone derivatives were synt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b146e0e03ced2e31023a5d4e44737371
https://pubmed.ncbi.nlm.nih.gov/10101030
https://pubmed.ncbi.nlm.nih.gov/10101030
Publikováno v:
Clinical chemistry. 38(6)
We describe the characterization and utility of a new electrochemiluminescent (ECL) label for oligonucleotides, utilizing phosphoramidite chemistry. This phosphoramidite of the tris(2,2-bipyridine)ruthenium(II) complex, bis(2,2-bipyridine)(4-[4-(2-cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44fceed429a4948250b3ca333b83c078
https://pubmed.ncbi.nlm.nih.gov/1597013
https://pubmed.ncbi.nlm.nih.gov/1597013
Autor:
Astorino TA; CSU, San Marcos, CA 92096, USA. astorino@csusm.edu, Willey J, Kinnahan J, Larsson SM, Welch H, Dalleck LC
Publikováno v:
British journal of sports medicine [Br J Sports Med] 2005 Sep; Vol. 39 (9), pp. 655-60; discussion 660.
Autor:
Ibrahim NK; Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. nibrahim@mdanderson.org, Buzdar AU, Valero V, Dhingra K, Willey J, Hortobagyi GN
Publikováno v:
Cancer [Cancer] 2001 Feb 15; Vol. 91 (4), pp. 664-71.
Autor:
Alfadhli A; Vollum Institute and Department of Microbiology, Oregon Health Sciences University, Portland, Oregon 97201-3098, USA., Love Z, Arvidson B, Seeds J, Willey J, Barklis E
Publikováno v:
Journal of virology [J Virol] 2001 Feb; Vol. 75 (4), pp. 2019-23.
Autor:
Jaborek-Hugo S; European Commission, DG Joint Research Centre, Institute for Health and Consumer Protection, Food Products and Consumer Goods Unit, Ispra, Italy., von Holst C, Allen R, Stewart T, Willey J, Anklam E
Publikováno v:
Food additives and contaminants [Food Addit Contam] 2001 Feb; Vol. 18 (2), pp. 121-7.
Autor:
Ibrahim NK; Division of Medicine, Department of Breast Medical Oncology, Box 56, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. nibrahim@mdanderson.org, Valero V, Rahman Z, Theriault RL, Walters RS, Buzdar AU, Booser DJ, Holmes FA, Murray JL 3rd, Willey J, Bast R, Hortobagyi GN
Publikováno v:
Cancer investigation [Cancer Invest] 2001; Vol. 19 (5), pp. 459-66.
Autor:
Snowden RJ; School of Psychology, Cardiff University, Wales, UK. snowden@cardiff.ac.uk, Willey J, Muir JL
Publikováno v:
Perception [Perception] 2001; Vol. 30 (8), pp. 983-91.